1.
Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013;153(1):17-37. doi:10.1016/j.cell.2013.03.002.
Eric Lander
1.
Germain AR, Carmody LC, Nag PP, et al. Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. Bioorg Med Chem Lett. 2013;23(6):1834-8. doi:10.1016/j.bmcl.2013.01.025.
1.
Pugh TJ, Morozova O, Attiyeh EF, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013;45(3):279-84. doi:10.1038/ng.2529.
1.
Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213-9. doi:10.1038/nbt.2514.
1.
Kirby A, Gnirke A, Jaffe DB, et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013;45(3):299-303. doi:10.1038/ng.2543.
1.
Grossman SR, Andersen KG, Shlyakhter I, et al. Identifying recent adaptations in large-scale genomic data. Cell. 2013;152(4):703-13. doi:10.1016/j.cell.2013.01.035.
1.
Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152(4):714-26. doi:10.1016/j.cell.2013.01.019.
1.
Drier Y, Lawrence MS, Carter SL, et al. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res. 2013;23(2):228-35. doi:10.1101/gr.141382.112.
1.
Gire SK, Stremlau M, Andersen KG, et al. Epidemiology. Emerging disease or diagnosis?. Science. 2012;338(6108):750-2. doi:10.1126/science.1225893.
1.
Sankaran VG, Ludwig LS, Sicinska E, et al. Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. Genes Dev. 2012;26(18):2075-87. doi:10.1101/gad.197020.112.